Key Insights

Highlights

Success Rate

86% trial completion

Research Maturity

65 completed trials (52% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

8.7%

11 terminated out of 126 trials

Success Rate

85.5%

-1.0% vs benchmark

Late-Stage Pipeline

12%

15 trials in Phase 3/4

Results Transparency

12%

8 of 65 completed with results

Key Signals

8 with results86% success11 terminated

Data Visualizations

Phase Distribution

66Total
Not Applicable (33)
Early P 1 (1)
P 1 (6)
P 2 (11)
P 3 (9)
P 4 (6)

Trial Status

Completed65
Unknown23
Recruiting13
Terminated11
Active Not Recruiting7
Not Yet Recruiting4

Trial Success Rate

85.5%

Benchmark: 86.5%

Based on 65 completed trials

Clinical Trials (126)

Showing 20 of 20 trials
NCT06948097Phase 1Not Yet RecruitingPrimary

Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies

NCT00457847Active Not Recruiting

Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation

NCT00552357Recruiting

Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation

NCT07716878Completed

Isavuconazole Therapeutic Drug Monitoring in Transplant Recipients

NCT07715617Recruiting

Development of a Prediction Score for the Occurrence of Death or Lung Transplantation in Patients With Emphysema Secondary to Alpha-1-anti-tripsin Deficiency

NCT05837663RecruitingPrimary

Trifecta-Lung cfDNA-MMDx Study

NCT01294020Phase 2Completed

Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

NCT07660991Not ApplicableCompletedPrimary

Evaluation of Hydroxymethylbutyrate Supplementation in Lung Transplant Candidates Receiving Pulmonary Rehabilitation

NCT07641647Phase 4Not Yet RecruitingPrimary

The Effect of Bupivacaine Liposomes on Postoperative Pain in Lung Transplant Patients After Intercostal Nerve Block: a Randomized Controlled Study

NCT06018766Phase 2Recruiting

LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.

NCT07525440CompletedPrimary

Neural Respiratory Drive Combined With Pro-Brain Natriuretic Peptide (Pro-BNP) as Predictor of Deterioration After Lung Transplantation

NCT06795516TerminatedPrimary

Observational Study on the Clinical Use of ex Vivo Lung Perfusion (XPS™) for Lung Transplantation

NCT03798860CompletedPrimary

Monitoring of Donor-specific Antibodies After Treatment With Immunoglobulins, Plasmapheresis and Rituximab in Lung Transplantation

NCT07479511Active Not RecruitingPrimary

Adaptation of Lung Transplant Recipients at Extreme Altitude

NCT05689905CompletedPrimary

Immunologic Risk of Pregnancy in Women With Lung Transplantion : a National Multicentric Study

NCT07356752Not ApplicableActive Not Recruiting

Prediction of Lung Transplant Outcome

NCT06853223Phase 2Recruiting

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

NCT07316829Active Not Recruiting

TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS

NCT05309551Not ApplicableActive Not RecruitingPrimary

Inspiratory Muscle Training Immediately After Lung Transplantation

NCT07291258Recruiting

Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation

Scroll to load more

Research Network

Activity Timeline